AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Addex Therapeutics Ltd American Depositary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00R48SV18
2.97▲ 0.08 (2.69%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
2.89
Day's Range
2.97 – 3.00
52-Week Range
2.56 – 10.72
Volume
7,242
Avg Volume
13.2K
Share Statistics
Shares Outstanding
Employees
2
Exchange
XNAS
Listed
2020-01-29
Share count as of December 31, 2025

Addex Therapeutics Ltd American Depositary Shares (ADXN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Addex Therapeutics Ltd American Depositary Shares (ADXN)
What is Addex Therapeutics Ltd American Depositary Shares's Market Cap?
Addex Therapeutics Ltd American Depositary Shares's Market Cap is $439.1M, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's Enterprise Value?
Addex Therapeutics Ltd American Depositary Shares's Enterprise Value is $438.1M, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's Price / Sales?
Addex Therapeutics Ltd American Depositary Shares's Price / Sales is 11625.5×, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's EV / Revenue?
Addex Therapeutics Ltd American Depositary Shares's EV / Revenue is 11600.3×, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's EV / EBITDA?
Addex Therapeutics Ltd American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's Revenue (TTM)?
Addex Therapeutics Ltd American Depositary Shares's Revenue (TTM) is $37.8K, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's Net Income (TTM)?
Addex Therapeutics Ltd American Depositary Shares's Net Income (TTM) is -$8.6M, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's EBITDA?
Addex Therapeutics Ltd American Depositary Shares's EBITDA is -$3.2M, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's Diluted EPS (TTM)?
Addex Therapeutics Ltd American Depositary Shares's Diluted EPS (TTM) is -0.06, based on as-reported figures from SEC (XBRL) filings.
What is Addex Therapeutics Ltd American Depositary Shares's EBITDA Margin?
Addex Therapeutics Ltd American Depositary Shares's EBITDA Margin is -8481.2%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ADXNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of CHF, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025
Condensed Consolidated Statements of Comprehensive Loss
Revenue from contract with customer
Other income
Operating costs
Research and development
General and administration
Total operating costs
Operating loss
Finance income
Finance expense
Finance result
Share of net loss of investments accounted for using the equity method
Net loss before tax from continuing operations
Net loss from continuing operations
Net profit from discontinued operations (attributable to equity holders of the Group)—
Net loss for the period
Basic loss per share for loss attributable to the ordinary equity holders of the Company
Diluted loss per share for loss attributable to the ordinary equity holders of the Company